Efficacy and Safety of Tideglusib in Congenital Myotonic Dystrophy
Clinical trial NCT03692312 · COMPLETED
Trial details
- NCT number
- NCT03692312
- Sponsor
- AMO Pharma Limited
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-03
- Primary completion
- 2023-04-04
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.